Raman Prakash — SEC Form 4 filings
SEC reporting owner CIK 2018686. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-04-12 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | Director | 13 | — | — | 13 |
| Olema Pharmaceuticals, Inc. (OLMA) | Director | 2 | — | — | 3 |
Form 4 filings — Raman Prakash
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 29,500 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 7,907 @ $1.66 | EDGAR |
| 2026-04-29 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 2,911 (derivative) @ $0 · Grant/award (A): 24,150 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 6,105 @ $2.15 | EDGAR |
| 2025-12-15 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 4,665 @ $2.76 | EDGAR |
| 2025-09-22 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 3,843 @ $3.35 | EDGAR |
| 2025-06-20 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 5,526 @ $2.33 | EDGAR |
| 2025-06-12 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 30,550 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 6,848 @ $1.88 | EDGAR |
| 2024-12-16 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 5,150 @ $2.50 | EDGAR |
| 2024-09-20 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 2,694 @ $4.78 | EDGAR |
| 2024-06-21 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 2,301 @ $4.98 | EDGAR |
| 2024-06-06 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 30,550 (derivative) @ $0 | EDGAR |
| 2024-04-12 | 4 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/award (A): 61,100 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2018686 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →